MedTrace Logo

Diabetes Management for Primary Healthcare Centers.

NCT06907472 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2026-03-27

No results posted yet for this study

Summary

The purpose of this study, "Integrating diabetes care into Primary Healthcare Centers (PHCs) in Abuja, Nigeria: a pilot study," is to screen, diagnose, treat, and educate diabetes patients in two selected PHCs in Abuja. This single-arm pilot trial will test the feasibility of integrated diabetes care, measure the implementation outcomes, and explore the effectiveness of the strategy bundle using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.

Conditions

  • Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG

Protocol-based treatment

PROTOCOL: Step 1: Metformin 500 mg daily Step 2: Metformin 1000 mg daily Step 3: Metformin 1000 mg twice daily Step 4: Metformin 1000 mg twice daily + glibenclamide 5 mg daily Step 5: Metformin 1000 mg twice daily + glibenclamide 5 mg twice daily

Sponsors & Collaborators

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • Northwestern University

    collaborator OTHER

  • Washington University School of Medicine

    collaborator OTHER

  • University of Abuja

    lead OTHER

Principal Investigators

  • Ikechukwu A. Orji, MBBS, PhD · University of Abuja

  • Dike B. Ojji, MBBS, PhD · University of Abuja

  • Lisa R. Hirschhorn, MD, MPH · Northwestern University Chicago

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-15
Primary Completion
2026-06-15
Completion
2026-12-14

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06907472 on ClinicalTrials.gov